5 Ways a Women’s Genetic Testing Provider Should Align with Your Value-Based Care Goals September 4, 2025 John Oberg, SVP Business Development/Strategy, Myriad Genetics Value-based care is still very much a long-term strategy within large and mid-size health s... Continue Reading
Genetic Testing in the C-Suite: Five Things Health System Leaders Need to Know Now September 4, 2025 Melissa Gonzales, President, Women’s Health, Myriad Genetics Although genetic tests and screens have been widely available for more than 30 years now, m... Continue Reading
The Clinical Impact of Myriad Women’s Health on Hereditary Cancer Risk Assessment and Genetic Testing September 4, 2025 Gabriel Lazarin, VP Medical Affairs, Women’s Health, Myriad Genetics Edie Smith, Doctor of Nursing Practice, Senior Medical Science Liaison, ... Continue Reading
Modernizing Genetic Counseling in Women’s Health Programs: Enhancing Clinical Workflows While Reducing Provider Burden September 4, 2025 Kaylee Henson, MS, CGC, Senior Product Manager, Pipeline Products, Myriad Genetics Susan Manley, MS, CGC, Senior VP Medical Services, Myriad Genetics ... Continue Reading
Ten Ways a Genetic Testing Provider Should Help Streamline Women’s Health Medical Management Operations September 4, 2025 Rent Baxley, Senior Director of Commercial Strategy, Myriad Genetics Every health system is trying to take cost, friction and complexity out of its geneti... Continue Reading